State-of-the-art imaging of peritoneal carcinomatosis;State-of-the-Art-Bildgebung bei Peritonealkarzinose

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 184, Issue 3, 2012, Pages 205-213

  Pfannenberg, Christina ^a   Schwenzer, N F ^a   Bruecher, B L ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CT; MR imaging; peritoneal carcinomatosis; PET CT; preoperative evaluation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CHEMOSURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIFFUSION WEIGHTED IMAGING; HUMAN; HYPERTHERMIC THERAPY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT SELECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857232614     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0031-1281979     Document Type: Article

References (60)

1. Glehen O, Kwiatkowski F, Sugarbaker PH et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol: 2004; 22 3284 3292 (Pubitemid 41103684)
2. Coakley FV, Choi PH, Gougoutas CA et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology: 2002; 223 495 499 (Pubitemid 34454332)
3. Sadeghi B, Arvieux C, Glehen O et al. Peritoneal carcinomatosis from non-gynecologic malignancies. Results of the EVOCAPE 1 Multicentric Prospective Study. Cancer: 2000; 88 358 363 (Pubitemid 30051820)
4. Sugarbaker PH. Peritonectomy procedures. Cancer Treat Res: 1996; 82 235 253
5. Al-Shammaa HA, Li Y, Yonemura Y. Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol: 2008; 14 1159 1166 (Pubitemid 351356322)
6. Esquivel J, Sticca R, Sugarbaker PH et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol: 2007; 14 128 133 (Pubitemid 44954279)
7. Brücher B, Königsrainer A. Die Peritonealkarzinose. CHAZ: 2010; 11 17 31
8. Verwaal VJ, van Ruth S, de Bree E et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol: 2003; 21 3737 3743 (Pubitemid 46606227)
9. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res: 1996; 82 359 374
10. Yan TD, Sim J, Morris DL. Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. Ann Surg Oncol: 2007; 14 1807 1817 (Pubitemid 46870939)
11. Königsrainer I, Aschoff P, Zieker D et al. Selektion zur Peritonektomie mit hyperthermer intraoperativer Chemotherapie (HIPEC) bei Peritonealkarzinose. Zentralbl Chir: 2008; 133 468 472
12. Meyers MA, Oliphant M, Berne AS et al. The peritoneal ligaments and mesenteries: pathways of intraabdominal spread of disease. Radiology: 1987; 163 593 604 (Pubitemid 17083212)
13. Levy AD, Shaw JC, Sobin LH. Secondary Tumors and Tumorlike lesions of the Peritoneal Cavity: Imaging Features with Pathologic Correlation. RadioGraphics: 2009; 29 347 373
14. Gore RM, Newmark GM, Thakrar KH et al. Pathways of abdominal tumour spread: the role of the subperitoneal space. Cancer Imaging: 2009; 9 112 120
15. Patel CM, Sahdev X XXX, Reznek RH. CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging: 2011; 11 123 139
16. Raptopoulos V, Gourtsoyiannis N. Peritoneal carcinomatosis. Eur Radiol: 2001; 11 2195 2206 (Pubitemid 33041084)
17. Yeh HC. Ultrasonography of peritoneal tumors. Radiology: 1979; 133 419 424
18. Hanbidge AE, Lynch D, Wilson SR. US of the Peritoneum. RadioGraphics: 2003; 23 663 685
19. Kyriazi S, Kaye SB, deSouza NM. Imaging ovarian cancer and peritoneal metastases - current and emerging techniques. Nat Rev Clin Oncol: 2010; 7 381 393
20. Gonzalez-Moreno S, Gonzalez-Bayon L, Ortega-Perez G et al. Imaging of Peritoneal Carcinomatosis. Cancer J: 2009; 15 184 189
21. Jacquet P, Jelinek JS, Steves MA et al. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer: 1993; 72 1631 1636 (Pubitemid 23249290)
22. Jacquet P, Jelinek JS, Chang D et al. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg: 1995; 181 530 538
23. Pannu HK, Bristow RE, Montz FJ et al. Multidetector CT of peritoneal carcinomatosis from ovarian cancer. RadioGraphics: 2003; 23 687 701 (Pubitemid 37431249)
24. De Bree E, Koops W, Kröger R et al. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol: 2004; 86 64 73 (Pubitemid 38580516)
25. Yan TD, Haveric N, Carmignani CP et al. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer: 2005; 103 839 849 (Pubitemid 40216414)
26. De Bree E, Koops W, Kröger R et al. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol: 2006; 32 65 71 (Pubitemid 43103990)
27. Yan TD, Morris DL, Shigeki K et al. Preoperative Investigations in the Management of Peritoneal Surface Malignancy with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: Expert Consensus Statement. J Surg Oncol: 2008; 98 224 227
28. Franiel T, Diederichs G, Engelken F et al. Multi-detector CT in peritoneal carcinomatosis: diagnostic role of thin slices and multiplanar reconstructions. Abdom Imaging: 2009; 34 49 54
29. Kim SJ, Kim H, Kim YH et al. Peritoneal Metastasis: detection with 16-or 64-Detector Row CT in Patients Undergoing Surgery for Gastric Cancer. Radiology: 2009; 253 407 415
30. Koh J, Yan TD, Glenn D et al. Evaluation of Preoperative Computed Tomography in Estimating Peritoneal cancer Index in Colorectal Peritoneal Carcinomatosis. Ann Surg Oncol: 2009; 16 327 333
31. Marin D, Catalano C, Baski M et al. 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging: 2010; 35 694 700
32. Choi HJ, Lim MC, Bae J et al. Region-based diagnostic performance of multidetector CT for detecting peritoneal seeding in ovarian cancer patients. Arch Gynecol Obstet: 2011; 283 353 360
33. Esquivel J, Chua TC, Stojadinovic A et al. Accuracy and Clinical Relevance of Computed Tomography Scan Interpretation of Peritoneal Cancer Index in Colorectal Cancer Peritoneal Carcinomatosis: A Multi-Institutional Study. J Surg Oncol: 2010; 102 565 570
34. Pfannenberg C, Königsrainer I, Aschoff P et al. 18F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol: 2009; 16 1295 1303
35. Tempany CM, Zou KH, Silverman SG et al. Staging of advanced ovarian cancer: comparison of imaging modalities - report from the Radiological Diagnostic Oncology Group. Radiology: 2000; 215 761 767 (Pubitemid 30346013)
36. Low RN, Semelka RC, Worawattanakul S et al. Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT in 164 patients. J Magn Reson Imaging: 2000; 12 269 277 (Pubitemid 30612871)
37. Ricke J, Sehouli J, Hach C et al. Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer. Eur Radiol: 2003; 13 943 949 (Pubitemid 36790585)
38. Low RN. MR imaging of the peritoneal spread of malignancy. Abdom Imaging: 2007; 32 267 283 (Pubitemid 47077103)
39. Fujii S, Matsusue E, Kanasaki Y et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol: 2008; 18 18 23 (Pubitemid 351217273)
40. Low RN, Sebrechts CP, Barone RM et al. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings - a feasibility study. Am J Roentgenol: 2009; 193 461 470
41. Bozkurt M, Doganay S, Kantarci M et al. Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values. Eur J Radiol: 2010; 10.1016/j.ejrad.2010.06.004
42. Kyriazi S, Collins DJ, Morgan VA et al. Diffusions-weighted Imaging of Peritoneal Disease for Noninvasive Staging of Advanced Ovarian Cancer. RadioGraphics: 2010; 30 1269 1285
43. Satoh Y, Ichikawa T, Motosugi U et al. Diagnosis of Peritoneal Dissemination: Comparison of 18F-FDG PET/CT, Diffusion-Weighted MRI, and Contrast-Enhanced MDCT. Am J Roentgenol: 2011; 196 447 453
44. Blodgett TM, Meltzer CC, Townsend DW. PET/CT: Form and Function. Radiology: 2007; 242 360 385 (Pubitemid 46150968)
45. Antoch G, Saoudi N, Kuehl H et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol: 2004; 22 4357 4368 (Pubitemid 41185156)
46. Fletcher JW, Djulbegovic B, Soares HP et al. Recommendations on the use of 18F-FDG-PET in Oncology. J Nucl Med: 2008; 49 480 508
47. Podoloff DA, Ball DW, Ben-Josef E et al. NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types. JNCCN: 2009; 7 1 23
48. Tanaka T, Kawai Y, Kanai M et al. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. Am J Surg: 2002; 184 433 436 (Pubitemid 35335951)
49. Turlakow A, Yeung HW, Salmon AS et al. Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nucl Med: 2003; 44 1407 1412 (Pubitemid 39663352)
50. Whiteford MH, Whiteford HM, Yee LF et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum: 2000; 43 759 767
51. Suzuki A, Kawano T, Takahashi N et al. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging: 2004; 31 1413 1420 (Pubitemid 39361938)
52. Mangili G, Picchio M, Sirini S et al. Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer. Eur J Nucl Med Mol Imaging: 2007; 34 658 666 (Pubitemid 46669366)
53. Dirisamer A, Schima W, Heinisch M et al. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT. Eur J Radiol: 2009; 69 536 541
54. Dirisamer A, Halpern BS, Flöry D et al. Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: Comparison with PET and enhanced CT. Eur J Radiol: 2010; 73 324 328
55. Berthelot C, Morel O, Girault S et al. Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy. Nucl Med Commun: 2011; 32 23 29
56. Kitajima K, Murakami K, Yamasaki E et al. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging: 2008; 35 1912 1920
57. Funicelli L, Travaini LL, Landoni F et al. Peritoneal carcinomatosis from ovarian cancer: the role of CT and 18F FDG-PET/CT. Abdom Imaging: 2010; 35 701 707
58. Gu P, Pan LL, Wu SQ. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma. A systematic review and meta-analysis. Eur J Radiol: 2009; 71 164 174
59. Pannu HK, Bristow RE, Cohade C et al. PET-CT in Recurrent Ovarian Cancer: Initial Observations. RadioGraphics: 2004; 24 209 223 (Pubitemid 38134606)
60. Pfannenberg AC, Königsrainer I, Aschoff P et al. 18F-FDG-PET/CT bei Peritonealkarzinose: Stellenwert im Rahmen der Patientenselektion zur zytoreduktiven Chirurgie und hyperthermen intraperitonealen Chemotherapie (HIPEC). Fortschr Röntgenstr: 2009; 181 S138